Companies: 10,795·Total market cap: $144.5T

CDT Equity Inc.

CDT Equity Inc.

CDTNASDAQHealthcare● Active

$0.78

+$0.04(+5.30%)

Market Cap$3765221

P/E Ratio—

52W High$610

52W Low$0.6859

Avg Volume911K

Open$0.74

Beta1.41

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

CDT Equity Inc.（CDT）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CDT · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-343.01Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$696.4MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding33,300Shares outstanding history

Next EarningsTBAEarnings history

探索 CDT Equity Inc. 数据

分析师预测—

股息不分红

盈利EPS $-1177.90+98.09%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$39.2M▼ 120.33% YoY

202320242025

FY 2025EPS$-1177.90▲ +98.09% YoY

202320242025

TTM:Revenue: $696.4MNet Income: $16.6MEPS: $-343.01View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

CDT Equity Inc.

$0.78+5.30%$3.8M #2

Concord Medical Services Holdings Limited

$4.78+0.00%$696,039.23 #3

Envoy Medical, Inc.

$0.66-0.33%$13.7M #4

Enveric Biosciences, Inc.

$1.75-2.78%$1.0M #5

Hepion Pharmaceuticals, Inc.

$0.06-23.75%$710,266 #6

Lixte Biotechnology Holdings, Inc.

$6.65-5.00%$82.3M

股票表现

1D+5.30%

1W-3.13%

1M-61.44%

3M-95.37%

YTD-97.58%

1Y-99.85%

5Y-100.00%

关于 CDT Equity Inc.

CEOAndrew Regan

IPO DateMar 28, 2022

Employees6

CountryUS

Websiteconduitpharma.com

CDT Equity Inc. Based in Naples, Florida, CDT Equity, Inc. commenced operations in October 2021. This firm, co-founded by David Joszef Tapolczay and Freda C. Lewis-Hall, focuses on aiding the advancement and market e…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

CDT Equity Inc.（CDT）是 Biotechnology 行业的 Healthcare 类公司，于 Mar 28, 2022 在 NASDAQ 上市。截至最近交易日，CDT 股价为 $0.78，市值约为 $3.8M。过去12个月累计回报 -99.85%，年初至今回报 -97.58%。

2025 财年 CDT Equity Inc. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，CDT Equity Inc.（CDT）股价为 $0.78，在 NASDAQ 上市，52周区间为 $0.69 – $610.00。

CDT 最新股价CDT quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议